The most successful treatments currently available include glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs), exemplified by semaglutide (approved in 2017, $19.9 billion sales in 2023) 3 and tirzepatide (approved in 2022, $5.3 billion sales in 2023) 4
doi: 10.1038/nature16460 56 SugimotoKOgawaAMizoguchiEShimomuraYAndohABhanAKet al
Figure 1 4 Overview of the GLP-1 mechanism GLP-1 is an incretin hormone composed of 3031 amino acids, produced by post-translational processing of proglucagon and secreted by intestinal L-cells in response to nutritional and inflammatory stimuli, as well as by neurons in the brainstem
The American journal of clinical nutrition, 87(5), 1558S1561S
Prescription Medical Weight Loss Programs (Telehealth) Our online weight loss clinic offers non-surgical, physician-supervised prescription weight loss programs